Overexpression of TRAF6 predicts a poor response to chemotherapy and radiotherapy for colorectal cancer patients, with molecular studies suggesting this is because TRAF6 regulates mitochondrial translocation of p538. The gene discussed is TRAF6; the disease is colorectal cancer.